JSP 545 (Digoxin 250 mcg (0.25 mg))
Pill imprint JSP 545 has been identified as Digoxin 250 mcg (0.25 mg).
Digoxin is used in the treatment of atrial fibrillation; heart failure and belongs to the drug classes group V antiarrhythmics, inotropic agents. Risk cannot be ruled out during pregnancy. Digoxin 250 mcg (0.25 mg) is not subject to the Controlled Substances Act.
See also related documents.
Images for JSP 545 (Digoxin 250 mcg (0.25 mg))
- 250 mcg (0.25 mg)
- Prescription only
- Drug Class:
- Group V antiarrhythmics
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Lannett Company, Inc.
- National Drug Code (NDC):
- Inactive Ingredients:
- silicon dioxide
|NDC Code||Manufacturer / Repackager|
|62584-0990||Amerisource Health Services|
|66336-0607||Dispensing Solutions Inc. (repackager)|
Note: Inactive ingredients may vary.
More about digoxin
- Digoxin solution
- Digoxin tablets
- Digoxin (Advanced Reading)
- Digoxin Intravenous (Advanced Reading)